A CVS Caremark audit finding on Patient Pay Amount collection turns on how a pharmacy waived a patient's copay, a separate audit question from whether the pharmacy collected it. The 2026 Caremark Provider Manual permits a financial hardship waiver only when it follows a written policy, an individualized determination of need, and audit-ready documentation. A waiver that cannot show those three things reads to the auditor as a routine waiver, the exact practice federal regulators have treated as unlawful since 1991.
Patient Pay Amount Findings in PBM Audits
A PBM audit examines Patient Pay Amount compliance as its own finding category, separate from whether a pharmacy collected the copay at all. Copay Collection Findings in PBM Audits addresses the collection side. This article addresses what happens when a pharmacy reduces or forgives that amount instead. Under Caremark's Section 3.03 Patient Pay, failure to collect the full Patient Pay Amount is treated as prima facie evidence of a Fraud, Waste and Abuse practice unless the pharmacy can show the reduction falls within one of two narrow exceptions: an individualized financial hardship determination, or documented exhaustion of reasonable collection efforts.
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
Financial Hardship Waivers: What PBM Audits Require
The hardship exception has governed copay waivers since the Office of Inspector General's May 1991 Special Fraud Alert on the routine waiver of Medicare Part B copayments and deductibles, republished in the Federal Register on December 19, 1994. The alert states that the hardship exception must not be used routinely; it applies occasionally, to the special financial needs of a particular patient. Absent that showing, a waiver can support liability under the Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) and the false claims statutes (18 U.S.C. §§ 287, 1001; 31 U.S.C. § 3729). PBM contracts build the same test into audit standards. Caremark's financial hardship program requires a written policy, an individualized application supported by federal tax returns or comparable documentation, annual re-verification, retained records of the application and approval, and approval by personnel who are not contractors or agents of the pharmacy. The program cannot be advertised, and it cannot be funded by a third party.
Collection efforts that begin only after a pharmacy receives a PBM audit notice do not count as reasonable collection efforts. Under the 2026 Caremark Provider Manual, that pharmacy is deemed to have waived the Patient Pay Amount.
Network Contract Terms and the Cost of an Undocumented Waiver
Caremark's Provider Manual sets a specific deadline on the collection-efforts exception: collection efforts initiated within 30 days of the prescription fill date count toward the reasonable-efforts defense. Collection efforts that begin only after Caremark's audit notice arrives do not, regardless of whether the pharmacy eventually collects the money. A violation of the Patient Pay section can trigger a chargeback on the claim, a recoupment demand across every similarly undocumented waiver in the lookback period, and, under the manual's violations provision, immediate network termination of the Provider Agreement. A pharmacy that disagrees with the finding can pursue an audit appeal, but the appeal record, discussed in CVS Caremark Audit Appeals: Deadlines and Procedural Defenses, is built from the same hardship-program documentation the pharmacy should have kept at the time of the waiver, not reconstructed after the fact.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a PBM audit notice that includes Patient Pay Amount or copay waiver findings. Early legal intervention can protect the pharmacy's rights, ensure appropriate responses to the PBM's document requests, avoid inadvertent admissions about collection practices, preserve the hardship-program documentation that supports an appeal, and allow counsel to communicate with the PBM's audit team directly. Delaying legal representation can significantly affect the outcome of the audit and expose the pharmacy to a larger recoupment demand and to termination from the network.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies nationwide against PBM audit findings on Patient Pay Amount collection and copay waivers, including findings that treat an undocumented hardship waiver as a routine waiver. Contact our PBM audit defense team for a free, confidential consultation.
